发布时间：2026-04-09 13:35 New interim results from a six-month investigator-initiated trial (IIT) supported by Galderma, regarding the clinical sequencing of women in menopause, show the combination of Restylane Skinboosters and Sculptra drove meaningful improvements in skin barrier function, hydration and patient satisfaction, with the most pronounced gains in hydration – a critical factor for perimenopausal skin health – observed when using Restylane Skinboosters first1
New interim data from a separate IIT show the cellular composition of adipose (fat) tissue may be altered in patients experiencing aesthetic changes in the abdomen following medication-driven weight loss, offering a biological explanation for clinicianreported volume loss beyond weight reduction alone, and underscoring the importance of including regenerative aesthetic treatments as part of the patients’ weight loss journey2
These data reinforce Galderma’s continuous support of independent research, in order to d
=*=*=*=*=*=
当前为第1/13页
下一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页